Cargando…
Production and separation of (43)Sc for radiopharmaceutical purposes
BACKGROUND: The favorable decay properties of (43)Sc and (44)Sc for PET make them promising candidates for future applications in nuclear medicine. An advantage (43)Sc (T(1/2) = 3.89 h, Eβ(+) (av) = 476 keV [88%]) exhibits over (44)Sc, however, is the absence of co-emitted high energy γ-rays. While...
Autores principales: | Domnanich, Katharina A., Eichler, Robert, Müller, Cristina, Jordi, Sara, Yakusheva, Vera, Braccini, Saverio, Behe, Martin, Schibli, Roger, Türler, Andreas, van der Meulen, Nicholas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824704/ https://www.ncbi.nlm.nih.gov/pubmed/29503855 http://dx.doi.org/10.1186/s41181-017-0033-9 |
Ejemplares similares
-
(44)Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations
por: Domnanich, Katharina A., et al.
Publicado: (2016) -
Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Domnanich, Katharina, et al.
Publicado: (2014) -
(47)Sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
por: Domnanich, Katharina A., et al.
Publicado: (2017) -
Therapeutic Potential of (47)Sc in Comparison to (177)Lu and (90)Y: Preclinical Investigations
por: Siwowska, Klaudia, et al.
Publicado: (2019) -
Separation of (44)Sc from (44)Ti in the Context of A Generator System for Radiopharmaceutical Purposes with the Example of [(44)Sc]Sc-PSMA-617 and [(44)Sc]Sc-PSMA-I&T Synthesis
por: Larenkov, Anton A., et al.
Publicado: (2021)